PRESS-RELEASE ·Filed Aug 14, 2026
Press release · M&A
Actionable Insight • Neutral
Filing ingested — full details in report page.
Latest settled — T+20d ⚠ clustered
ATNM ▲ +19.05% at T+20d
NEUTRAL call +19.05% · α vs SPY +21.03% · entry $1.05 → $1.25
Latest observation: T+48 +69.43% FF3 residual α
T+1d
+2.86%
call +2.86% · α +3.53%
$1.08
settled 2mo ago
T+5d
0.00%
call 0.00% · α +1.19%
$1.05
settled 2mo ago
T+20d
+19.05%
call +19.05% · α +21.03%
$1.25
settled 6w ago
T+60d
Pending
in 14d
Price Chart
Loading chart...
Executive Summary
No summary provided
Financial Impact
Not specified
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
78% bullish (9 analysts)
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302851567 |
6 reports for ATNM
67% Hit rate @ T+20 Went positive at some point 2 of 3 best @ T+20▲ +16.95%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | DEF 14A | $1.13 | awaiting T+20 | — | $1.40 (+23.72%) |
Oct 15, 2026 10d ago | 8-K | $1.13 | awaiting T+20 | — | $1.40 (+23.72%) |
Aug 14, 2026 10w ago | Press Release | $1.05 $1.25 | ▲ +19.05% | ▲ +21.03% | $1.40 (+33.14%) |
Aug 14, 2026 10w ago | 8-K | $1.05 $1.25 | ▼ −19.05% | ▼ −21.03% | $1.40 (−33.14%) |
Jun 18, 2026 18w ago | 8-K | $1.03 $0.9219 | ▲ +10.50% | ▲ +10.35% | $1.40 (−35.73%) |
May 29, 2026 21w ago | 8-K | $1.18 $0.9800 | ▲ +16.95% | ▲ +15.65% | $1.40 (−18.47%) |
Showing 6 of 6
US Market Status
Market Open — Closes in 2m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers